GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Cash Flow from Financing

Bangkok Genomics Innovation PCL (BKK:BKGI) Cash Flow from Financing : ฿247.6 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, Bangkok Genomics Innovation PCL paid ฿0.0 Mil more to buy back shares than it received from issuing new shares. It spent ฿1.4 Mil paying down its debt. It paid ฿0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ฿0.0 Mil from paying cash dividends to shareholders. It received ฿2.0 Mil on other financial activities. In all, Bangkok Genomics Innovation PCL earned ฿0.6 Mil on financial activities for the three months ended in Dec. 2024.


Bangkok Genomics Innovation PCL Cash Flow from Financing Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Cash Flow from Financing Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial -7.73 -3.25 18.06 -49.66 247.56

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.34 249.81 -1.40 -1.40 0.56

Bangkok Genomics Innovation PCL Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Bangkok Genomics Innovation PCL's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Bangkok Genomics Innovation PCL's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿247.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Genomics Innovation PCL  (BKK:BKGI) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Bangkok Genomics Innovation PCL's issuance of stock for the three months ended in Dec. 2024 was ฿0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Bangkok Genomics Innovation PCL's repurchase of stock for the three months ended in Dec. 2024 was ฿0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Bangkok Genomics Innovation PCL's net issuance of debt for the three months ended in Dec. 2024 was ฿-1.4 Mil. Bangkok Genomics Innovation PCL spent ฿1.4 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Bangkok Genomics Innovation PCL's net issuance of preferred for the three months ended in Dec. 2024 was ฿0.0 Mil. Bangkok Genomics Innovation PCL paid ฿0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Bangkok Genomics Innovation PCL's cash flow for dividends for the three months ended in Dec. 2024 was ฿0.0 Mil. Bangkok Genomics Innovation PCL received ฿0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Bangkok Genomics Innovation PCL's other financing for the three months ended in Dec. 2024 was ฿2.0 Mil. Bangkok Genomics Innovation PCL received ฿2.0 Mil on other financial activities.


Bangkok Genomics Innovation PCL Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL Business Description

Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.

Bangkok Genomics Innovation PCL Headlines